Current Alzheimer Research
Title: Erratum
Volume: 2 Issue: 1
Export Options
About this article
Cite this article as:
Erratum, Current Alzheimer Research 2005; 2 (1) . https://dx.doi.org/10.2174/1567205052772777
DOI https://dx.doi.org/10.2174/1567205052772777 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
12
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Aging, Mitochondria and Male Reproductive Function
Current Aging Science Synthetic Androgens as Designer Supplements
Current Neuropharmacology Autoimmune Diseases and Atherosclerosis: The Inflammatory Connection
Current Immunology Reviews (Discontinued) Tumor Necrosis Factor Blockade for Treatment of Inflammatory Bowel Disease: Efficacy and Safety
Current Molecular Pharmacology Impact of MCP -1 in Atherosclerosis
Current Pharmaceutical Design Anti-Chlamydophila pneumoniae Antibodies as Associated Factor for Carotid Atherosclerosis in Patients with AIDS
Current HIV Research Experimental Models of Discovery: Prediction and Protection must Proceed “Hand-in-Hand”
Current Neurovascular Research Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) Recent Advances in the Treatment of Neurogenic Erectile Dysfunction
Recent Patents on CNS Drug Discovery (Discontinued) Towards Next Generation Adenosine A<sub>2A</sub> Receptor Antagonists
Current Medicinal Chemistry Association of SORL1 Alleles with Late-Onset Alzheimer's Disease. Findings from the GIGAS_LOAD Study and Mega-Analysis
Current Alzheimer Research Meet Our Editorial Board Member
Current Organic Synthesis The Management of Phosphodiesterase-5 (PDE5) Inhibitor Failure
Current Vascular Pharmacology Fructose-1,6-bisphosphatase Inhibitors: A Review of Recent (2000- 2017) Advances and Structure-Activity Relationship Studies
Current Medicinal Chemistry Tamoxifen as a Powerful Neuroprotectant in Experimental Stroke and Implications for Human Stroke Therapy
Recent Patents on CNS Drug Discovery (Discontinued) Formulation and Evaluation of α-Pinene Loaded Self-emulsifying Nanoformulation for <i>In-Vivo</i> Anti-Parkinson's Activity
Recent Patents on Nanotechnology Commentary: Research Highlights ATF4: The Perpetrator in Axonal-Mediated Neurodegeneration in Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Exposure of Aggregation-Prone Segments is the Requirement for Amyloid Fibril Formation
Current Protein & Peptide Science Identification of Small Molecule as a High Affinity β2 Agonist Promiscuously Targeting Wild and Mutated (Thr164Ile) β 2 Adrenergic Receptor in the Treatment of Bronchial Asthma
Current Pharmaceutical Design Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward
Current Alzheimer Research